Galderma has a wide range of specialized products covering everything from skin care to topical treatments for major dermatological conditions.
Capex® Shampoo is a unique corticosteroid treatment in a shampoo-delivery system created to effectively treat inflammatory diseases of the scalp, such as itch and dandruff associated with seborrheic dermatitis.
Treatment is simple and quick. Just once a day for five minutes is all it takes for Capex® Shampoo to treat the inflammatory diseases related to seborrheic dermatitis.
Millions of Americans are affected by seborrheic dermatitis. This noncontagious skin disorder may appear as red, inflamed skin covered by greasy or dry scales that are often white, yellowish, or gray. Anyone at any age can develop seborrheic dermatitis. Not for use on patients < 12 years of age.
For more information about Capex® Shampoo, visit www.capexshampoo.com.
Full Prescribing Information
Maintaining healthy skin throughout your life takes discipline and diligence. Following a skin care regimen that includes daily use of Cetaphil® products is the first step toward a healthy skin.
Whether you're looking for moisturizers, cleansers or non-soap bars, Cetaphil® products are an ideal complement to treatments for a host of common skin conditions. They gently cleanse, soothe and soften dry skin without harming your skin's natural protective barrier or normal pH balance.
To find out which Cetaphil® product is right for you, visit www.cetaphil.com.
Interested in seeing a dermatologist Locate one in your area with the DermFinder.
 Clindagel® topical gel is a clinically proven once-a-day treatment for acne. It reduces the inflammation and blemishes caused by acne. It’s oil-free and alcohol-free; its gel formulation is easy to spread, absorbs quickly and feels smooth on your skin.
To learn whether Clindagel® is right for you, visit www.clindagel.com.
Acne is one of the most common of all skin problems. It affects most teenagers and even many adults. Acne shows up as whiteheads, blackheads, pimples, and in some people, deep painful bumps that look and feel like boils.
Clindagel® is contraindicated in patients with a history of hypersensitivity to clindamycin or lincomycin, regional enteritis or ulcerative colitis, or antibiotic-associated colitis. Use during pregnancy only if clearly needed. Diarrhea, bloody diarrhea and pseudomembranous colitis have been reported with topical clindamycin. Discontinuation is recommended if significant diarrhea develops.
To locate a dermatologist in your area, use DermFinder.
Full Prescribing Information
 Clobex® Lotion provides the strength of clobetasol cream with the light consistency of a lotion. . It’s easy-to-use, absorbs quickly into the skin.
Clobex® Shampoo combines the power of clobetasol with convenience. An easy-to-use scalp psoriasis product, Clobex® Shampoo is applied just once a day for four weeks delivering serious treatment power to your daily shower!
For more information on Clobex® Lotion, 0.05%, Clobex® Shampoo, and Clobex® Spray, visit www.clobex.com.
Psoriasis is a disorder in which skin grows and replaces itself too rapidly, causing a buildup of red, thickened areas with silvery scales. Psoriasis usually develops on the scalp, elbows, knees and lower back.
To locate a dermatologist in your area, use DermFinder.
Full Prescribing Information: Clobex® Spray, Clobex® Lotion, and Clobex® Shampoo
It is applied directly to the face or affected area and is thought to work deep inside your pores to control the cause of the buildup that leads to the formation of acne. Available in a variety of formulations: gel, solution, and cream.
To get the full story on all Differin® products, visit www.differin.com.
Acne most commonly occurs on the face but can also appear on the back, chest, shoulders and neck. It is estimated that as many as 70 million people suffer from acne. In most people, acne clears up after a few years. But at its worst, acne can cause permanent scarring of the skin.
If you think you may have acne, use our Self-Assess Your Skin Tool to find out more.
Differin® products are only available by prescription, so plan to visit a dermatologist. To locate one in your area, use DermFinder.
Full Prescribing Information
METROGEL® 1% is the most powerful strength of topical metronidazole available in the gel formulation to treat inflammatory lesions associated with rosacea. METROGEL 1% is now available in the innovative new pump delivery system. The new dispenser design of the METROGEL 1% Pump was US FDA approved in October 2011. The new pump makes it simpler for patients to use the treatment and it will provide consistent measured dosing so that rosacea patients can consistently use their medication. According to the Patient Preference Study involving 207 diagnosed rosacea patients, 69% of the patients preferred the pump over the tube, for dispensing a prescription rosacea medication. These patients believed that the innovative pump delivery system may help increase their compliance with their rosacea treatment regimen due to its ease of use and convenience.1
More than 16 million Americans are estimated to have rosacea, and while there is no cure, proper treatment can make it manageable.2 Patients who used MetroGel® 1% experienced a 71% median reduction in inflammatory lesions (bumps and blemishes) after 10 weeks of treatment.3 MetroGel® 1% has an exclusive formula that contains HSA-3®, which is a combination of ingredients including betadex, niacinamide (vitamin B3), and propylene glycol. In a 92% water-based gel, these ingredients work together to help skin retain moisture while enhancing absorption of metronidazole. In clinical trials, the most common side effects reported are sore throat/nasal congestion, upper respiratory tract infections, headaches, skin irritation, burning, dryness and transient redness. Patients also sometimes report a metallic taste and tingling or numbness in the extremities when using topical metronidazole.3
References:
1. Data on File. Galderma Laboratories, L.P.
2. The National Rosacea Society. “What Is Rosacea”. http://www.rosacea.org/index.php. Accessed on November 15, 2010.
3. MetroGel 1% Prescribing Information
Full Prescribing Information
Cleanser combines the active ingredients sodium sulfacetamide 10% and sulfur 5%. Both ingredients prevent the growth of bacteria and fungi on the skin, which can cause pustules and papules associated with acne, rosacea or seborrheic dermatitis.
Rosanil® Cleanser is unique to other sodium sulfacetamide/sulfur cleansers on the market because it contains no masking fragrances that can irritate sensitive skin. To learn more about Rosanil® Cleanser, visit www.rosanil.com.
If you would like to visit a dermatologist and need to locate one in your area, use DermFinder.
Full Prescribing Information
This powerful combination of three active ingredients is more effective than any of the individual components in reducing the darkened skin caused by melasma.*
Visible proof can be seen in as little as 4 weeks, with maximum results seen in 8 weeks. This convenient, well-tolerated cream is applied nightly before bed. To learn whether Tri-Luma® Cream is right for you, visit www.triluma.com.
Full Prescribing Information
If you would like to visit a dermatologist and need to locate one in your area, use DermFinder.
* Data on file, Galderma Laboratories, L.P.
DesOwen® Lotion is a low-potency topical steroid used to treat a variety of skin disorders such as eczema and atopic dermatitis. This white, creamy, moisturizing lotion spreads easily and is especially suitable for treating large body areas and thin skin areas. It is more effective than hydrocortisone lotion 2.5% and safe hydrocortisone 1.0%.
DesOwen® Lotion is well tolerated. DesOwen® products come in lotion, cream and ointment form and are available by prescription only.
Eczema is a term to describe specific skin diseases, including atopic dermatitis, contact dermatitis, hand dermatitis and asteatotic eczema. It is an itchy, red, scaling, weeping, oozing skin condition. Seborrheic dermatitis is a noncontagious skin disorder that may appear as red, inflamed skin covered by greasy or dry scales that are often white, yellowish or gray.
In controlled clinical trials, the total incidence of adverse reactions associated with the use of desonide was approximately 8%. These were stinging and burning approximately 3%; irritation, contact dermatitis, condition worsened, peeling of the skin, itching, intense transient erythema, and dryness/scaliness, each less than 2%.
If you would like to visit a dermatologist and need to locate one in your area, use DermFinder.
Full Prescribing Information
Benzac® AC Gel and Wash are therapeutic, water-based benzoyl peroxide treatments especially formulated for women with adult acne and teens with adolescent acne.
Benzac® AC incorporates acrylates copolymer technology to deliver moisturizing glycerin to dry, sensitive skin and absorb excess facial sebum. Micronized benzoyl peroxide assures a smooth-textured, consistent formulation.
Benzac® AC Gel is indicated for the topical treatment of acne. Its moisturizing formulation is perfect for treating women with adult acne, who can have both acne and dry, sensitive skin. Teenagers with adolescent acne who have extremely dry or sensitive skin are also good candidates for treating with Benzac® AC Gel.
Benzac® AC Wash is a therapeutic water-based skin cleansing lotion that moisturizes while it treats acne. It effectively and gently cleanses the skin prior to further acne treatment.
Acne is one of the most common of all skin problems. Caused by an increase in the production of hormones, acne affects most teenagers and even many adults.
If you think you may have eczema, seborrheic dermatitis or acne, use our Self-Assess Your Skin Tool to find out more. To locate a dermatologist in your area, use DermFinder.
Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy.
If you would like to visit a dermatologist and need to locate one in your area, use DermFinder.
Full Prescribing Information
 Oracea® (OR-AY-SHA) (doxycycline, USP) Capsule is the first and only oral therapy approved by the FDA to treat rosacea*.
Living with rosacea can sometimes be challenging—but there is also good news. Although rosacea cannot be cured, it can now be treated in a way that reduces flare-ups and shortens the duration of rosacea episodes. Once-daily Oracea® the first and only oral therapy available and provides effective rosacea treatment.1
The important thing is to talk with your dermatologist to find out about the many treatment options available. With rosacea, the sooner you begin treatment the better.2
One of your best defenses is knowledge. Click on the links below to discover important facts about Oracea® for rosacea. Then ask your doctor if Oracea® is right for you.
References: 1. Del Rosso JQ, Webster, GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol. 2007;56(5):791-802.
2. Heymann WR. Rosacea subtype-directed therapy. J Am Acad Dermatol. 2004;51(1):90-92.
Full Prescribing Information
Epiduo® Gel is a new prescription medication for acne. It contains two acne-fighting ingredients, a retinoid called adapalene and benzoyl peroxide. It’s the only FDA-approved topical acne treatment with this powerful combination.
Full Prescribing Information
The combination of Metvixia® (methyl aminolevulinate) Cream, 16.8% (“Metvixia”) and Galderma’s Aktilite® CL128 LED (light-emitting diode) lamp represent the next generation of photodynamic therapy for the treatment of actinic keratoses (“AK”).
Actinic keratoses are very common lesions that occur on sun-damaged skin and are widely considered to be a precursor to squamous cell carcinoma.
Metvixia is a topical porphyrin precursor used in photodynamic therapy. When applied to actinic keratosis lesions, Metvixia is selectively absorbed into precancerous cells causing a build-up of endogenous porphyrins. These endogenous porphyrins are illuminated with the Aktilite CL128 lamp emitting a narrow output spectrum of red light with a peak wavelength at 630 nm. Subsequently, a reaction occurs that results in the destruction of the precancerous cells. Clinical trials in various countries with the Metvixia PDT system have shown comparable or better response rates than conventional treatments, such as cryotherapy or surgery. Metvixia PDT selectively targets precancerous cells so the surrounding healthy cells are less subjected to the treatment, therein minimizing scarring and ensuring more acceptable cosmetic outcomes for patients. In clinical trials, the most commonly reported adverse events associated with use of Metvixia PDT were contact sensitization, erythema, pain, burning, and skin discomfort/irritation.
Full Prescribing Information
|